Pay in 4 interest-free payments of $6.62 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
Potent derivatives of glucagon-like peptide-1 with pharmacokinetic properties suitable for once daily administration
The same mission: to make evidence-based obesity care accessible to all
Retatrutide has the most promising metabolic profile but the least long-term cardiac data
Enhanced biomechanical strength of healing ligaments in animal studies suggests potential for reduced re-injury risk and faster return to activity
Participants received either tirzepatide at 5mg, 10mg, or 15mg weekly, or placebo, for 72 weeks
US$ 28.39
US$ 20.93
US$ 24.41
US$ 20.20
US$ 24.66
US$ 26.49
US$ 26.88
US$ 28.52
